Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9032 |
High Similarity |
NPD6234 |
Discontinued |
0.8831 |
High Similarity |
NPD37 |
Approved |
0.8782 |
High Similarity |
NPD4965 |
Approved |
0.8782 |
High Similarity |
NPD4967 |
Phase 2 |
0.8782 |
High Similarity |
NPD4966 |
Approved |
0.8758 |
High Similarity |
NPD7228 |
Approved |
0.8447 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD7240 |
Approved |
0.8163 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7987 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7976 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7881 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7866 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7833 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7816 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7744 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7702 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7663 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7644 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7586 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7545 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7543 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.753 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7485 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7425 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7425 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7362 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5762 |
Approved |
0.733 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.732 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7226 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7188 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7181 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7178 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7171 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7168 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.712 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7111 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7111 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7108 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7105 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7039 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7035 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7018 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7018 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7012 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.701 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.6988 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6988 |
Remote Similarity |
NPD6799 |
Approved |
0.6986 |
Remote Similarity |
NPD228 |
Approved |
0.6982 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6977 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD5402 |
Approved |
0.6977 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6961 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6959 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6954 |
Remote Similarity |
NPD919 |
Approved |
0.6951 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6941 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6933 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6914 |
Remote Similarity |
NPD3748 |
Approved |
0.6909 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6908 |
Remote Similarity |
NPD4626 |
Approved |
0.6905 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD3749 |
Approved |
0.6893 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6883 |
Remote Similarity |
NPD1608 |
Approved |
0.6882 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6882 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6879 |
Remote Similarity |
NPD5353 |
Approved |
0.6879 |
Remote Similarity |
NPD5736 |
Approved |
0.6875 |
Remote Similarity |
NPD4140 |
Approved |
0.6875 |
Remote Similarity |
NPD5005 |
Approved |
0.6875 |
Remote Similarity |
NPD5006 |
Approved |
0.6871 |
Remote Similarity |
NPD6032 |
Approved |
0.6867 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD5403 |
Approved |
0.6859 |
Remote Similarity |
NPD2797 |
Approved |
0.6855 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6849 |
Remote Similarity |
NPD3021 |
Approved |
0.6849 |
Remote Similarity |
NPD3022 |
Approved |
0.6845 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD5691 |
Approved |
0.6836 |
Remote Similarity |
NPD5710 |
Approved |
0.6836 |
Remote Similarity |
NPD5711 |
Approved |
0.6829 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6829 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6821 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD6746 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD1281 |
Approved |
0.681 |
Remote Similarity |
NPD4108 |
Discontinued |
0.681 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6807 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6802 |
Remote Similarity |
NPD7411 |
Suspended |
0.68 |
Remote Similarity |
NPD4055 |
Discovery |
0.6798 |
Remote Similarity |
NPD5242 |
Approved |
0.6797 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6797 |
Remote Similarity |
NPD5126 |
Approved |
0.6795 |
Remote Similarity |
NPD6696 |
Suspended |
0.6788 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6784 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD7906 |
Approved |
0.677
|
Remote Similarity |
NPD1240 |
Approved |